RecruitingGestational DiabetesObesityHealthy
Growth Hormone Resistance of Beta-cells A
Eligible age
18–45 yrs
Accepts
Women
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with a personal history of gestational diabetes (high blood sugar in pregnancy) at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing gestational diabetes.
Sponsor: University of Missouri-Columbia
You may qualify if…
- ✓ Singleton, full term pregnancy within the past 5 years
- ✓ Body mass index ≥18.5 kg/m2 and \<45.0 kg/m2
- ✓ Group specific inclusion criteria:
- ✓ Gestational Diabetes Group: History of gestational diabetes in the most recent pregnancy
- ✓ Control Group: no history of gestational diabetes
You may not qualify if…
- ✕ Pregnant, planning to become pregnant during the study, or breastfeeding
- ✕ Current diagnosis or history of type 1 or type 2 diabetes
- ✕ Use of medications that can impact the study outcomes (e.g., GLP-1 receptor agonists)
- ✕ History of bariatric surgery
- ✕ Known, uncontrolled hypothyroidism
- ✕ History of intracranial hypertension, including papilledema, or a condition that increases the risk of developing intracranial hypertension, such as Turner Syndrome, Prader-Willi Syndrome, or renal impairment
- ✕ Current cancer or cancer that has been in remission less than 5 years
- ✕ First degree relative with diabetes diagnosis
Where it's recruiting
Missouri
Columbia
Source: ClinicalTrials.gov · NCT06571487 · last updated 2026-05-11